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Introduction: Malignant metastases to the oral cavity are rare and metastatic melanomas of the tongue are conside-
red exceptionally uncommon, with less than 10 cases published in the English literature so far. 
Case reports: Two female patients in the 7th decade of life presented to our dental service with nodules in the ton-
gue. Both patients had multiple metastases at the time of oral diagnosis and primary melanoma originated on the 
skin. An intra-oral incisional biopsy was performed under local anesthesia and the histopathologic analysis was 
characterized by the proliferation of atypical epithelioid cells displaying a poorly delimited cytoplasm and hyper-
chromatic nucleus which contained eosinophilic macronucleoli. Immunohistochemistry was performed in both 
cases to confirm the clinical hypothesis of metastatic melanoma. After the diagnosis of oral metastatic melanoma, 
the patients were maintained under palliative care and close medical follow-up. Both patients died four and a half 
months and 20 months after the diagnosis of tongue metastasis. 
Conclusions: Although rare, metastatic melanoma should be included in the differential diagnosis of tongue lesions 
detected in patients with a previous medical history of cutaneous melanoma. 
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Introduction
Melanomas are malignant tumors that originate from 
skin melanocytes and are considered one of the most ag-
gressive types of cancer. Once considered a rare tumor, 
the incidence of cutaneous melanoma is estimated to be 
increasing worldwide and usually affects young adults. 
Solar UV radiation is a well-established risk factor for 
melanoma, as the most frequently affected sites inclu-
de sun-exposed areas of fair-skinned patients, such as 
the dorsal surface of the trunk of the body, arms, legs 
and the head and neck region. Late diagnosis is often 
associated with advanced disease characterized by dis-
semination to regional lymph nodes and distant metasta-
ses, leading to a five-year survival rate of 5%. Surgical 
treatment combined with radiotherapy, chemotherapy 
and molecular targeted therapy have been used in the 
treatment of melanoma (1-3).
Primary oral melanomas account for approximately 1% 
of all cases; the most commonly affected intraoral sites 
are the palate and the maxillary gingiva. Similarly, oral 
metastases derived from primary melanomas located at 
distant sites are considered extremely rare (4). In this 
scenario, only eight cases of metastatic melanoma of the 
tongue have been reported in the English literature so far 
(Table 1). Therefore, the aim of this article was to report 
two new cases of primary cutaneous melanoma metas-
tasizing to the tongue and to further review the current 
knowledge regarding melanoma metastases to the oral 
cavity and tongue. 
Case Report
Case 1
A 62-year-old female patient was referred by her onco-
logist for a routine dental evaluation. The patient’s me-
dical history revealed a cutaneous melanoma of the left 
dorsum diagnosed six years before she was referred to 
our dental service. The tumor was primarily treated by 
surgery and developed two local recurrences (one and 
three years following surgery, respectively), which were 
also managed by surgical resection. Disease progression 
was identified five years after the first treatment and con-
firmed by a computed tomography (CT), which revealed 
multiple organ involvement including the lungs, skin 
(subcutaneous nodules on the dorsum) and bone (os-
teolytic lesions in the iliac and femur bones, ribs, verte-
brae, sternum and scapula). 
The patient was undergoing a palliative treatment proto-
col based on dacarbazine, zoledronic acid and radiothe-
rapy in the lumbar region (total dose of 20 Gy) and in the 
left supraclavicular fossa (total dose of 36 Gy) when she 
was referred to our dental facility. An extraoral clinical 
examination identified a pigmented subcutaneous nodu-
le on the patient’s dorsum, measuring 5 cm in diameter, 
and scarring from the previous surgical resections. 
The patient’s chief complaint was the loss of the dental 
crown of her upper left incisor. She denied oral pain or 
the existence of any relevant oral soft tissue lesion. In-
traoral soft tissue examination revealed a nodule with 
an ulcerated surface and areas of telangiectasia, on the 
 
Case Author Sex Age Primary site Metastases Treatment Time from primary 
tumor to tongue 
metastasis 
1 Zegarelli et al, 1973(5) M 47 Skin Tongue, Lung, skin and liver Unknown 2.5 yrs 
2 
 
Patton et al, 1994(1) F 26 Skin Tongue P surgical resection CHT 




Patton et al, 1994(1) M 27 Skin Tongue P surgical resection CHT 
and IMT, R RND 
8.1 yrs 
4 Patton et al, 1994(1) F 47 Skin Tongue P surgical resection and 
CHT, R RND 
4.5 yrs 
5 Patton et al, 1994(1) M 51 Skin Tongue P and ORL surgical 
resection, R AxND, P 
CHT, ORL RT 
6 yrs 
6 Patton et al, 1994(1) F 52 Skin Tongue P surgical resection, P 
CHT 
3.2 yrs 
7 Alves et al, 1994(6) M 72 Skin Tongue P and ORL surgical 
resection, IngND 
1.25 yrs 
8 Tas et al, 2015(7) F 79 Skin Tongue, Skin, subcutaneous and 
muscular tissues and lymph nodes. 
P surgical resection, 
IngND, P CHT and IMT, 
palliative CHT and ORL 
RT 
10 yrs 
9 Case 1, 2018 F 62 Skin Tongue, dorsum, osteolytic lesions 
in the iliac and femur bones, ribs, 
vertebrae, sternum, scapula and 
lungs. 
P and ORL surgical 
resection, palliative CHT 
6 yrs 
10 Case 2, 2018 F 62 Skin Tongue, subclavicular mass, 
retroperitoneal region and central 
nervous system. 
P and ORL surgical 
resection, palliative CHT 
4 yrs 
 
Table 1: Literature review of 8 cases of melanoma metastatic to the tongue.
CHT, Chemotherapy; P, Primary tumor; ORL, Oral metastasis; B, Bilateral; RND, Radical neck dissection; RT, Radiotherapy; IMT, Immuno-
therapy; R, Right; AxND, Axillary node dissection; IngND, Inguinal node dissection..
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Fig. 1: A. Clinical aspect of an exophytic nodule on the left posterior border of the tongue. B. Histopathological findings of the 
tongue lesion revealing the proliferation of atypical, pleomorphic, malignant tumor cells. C. Immunohistochemistry positivity for 
S100.
posterior left lateral border of the tongue, measuring 
approximately 1 cm in diameter, adjacent to a partial 
edentulous mandibular area (Fig. 1A). Based on the cli-
nical features of the tongue lesion and on the patient’s 
medical background, the diagnostic hypothesis included 
metastatic melanoma, squamous cell carcinoma and fi-
brous hyperplasia. 
An incisional biopsy was performed under local anes-
thesia. The histopathological analysis showed nests and 
solid sheets of non-pigmented atypical cells with an epi-
thelioid phenotype infiltrating the sub-epithelial connec-
tive tissue. A high mitotic index was observed (Fig. 1B). 
Tumor cells displayed diffuse immustaining for S100 
protein. Other melanocytic markers such as HMB-45 
and Melan-A were negative. (Fig. 1C).
After the diagnosis of a metastatic lesion on the tongue, 
the patient was referred back to the clinical oncologist 
who maintained her in a palliative protocol of chemothe-
rapy with cisplatin, dacarbazine and vinblastine (CVD). 
Unfortunately, the patient died due to disease progres-
sion four and a half months after the diagnosis of tongue 
metastasis.
Case 2
A 62-year-old female was diagnosed with an acral lenti-
ginous melanoma on the right heel four years previously. 
At that time, CT revealed pulmonary nodules and the 
patient was kept in close follow-up. Two years after the 
initial diagnosis, the patient was submitted to a pulmo-
nary biopsy with a diagnosis of metastatic melanoma. 
Four months later, the patient requested a dental evalua-
tion due to a fast-growing submucosal nodular lesion on 
her tongue.
During the first dental appointment, intraoral soft tissue 
examination revealed a submucosal nodule in the right 
dorsum of the tongue measuring approximately 2 cm in 
diameter and firm upon palpation (Fig. 2A). The patient 
reported three months of painless nodule progression. 
Based on the previous medical history of the patient, 
the diagnostic hypothesis included metastatic melanoma 
and benign mesenchymal neoplasm.
An intra-oral incisional biopsy was performed under lo-
cal anaesthesia. The histopathologic analysis was cha-
racterized by proliferation of atypical epithelioid cells 
displaying a poorly delimited cytoplasm and hyperchro-
matic nucleus which contained eosinophilic macronu-
cleoli (Fig. 2B). Immunohistochemistry showed multi-
focal staining for melanocytic markers, including S100 
(Fig. 2C), HMB-45 (Fig. 2D) and Melan-A (Fig. 2E). 
These findings confirmed the clinical hypothesis of me-
tastatic melanoma.
After diagnosis, the patient was referred back to the cli-
nical oncologist who investigated a left subclavicular 
mass with a diagnosis of metastatic melanoma and also 
presented disease progression to the lungs, retroperito-
neal region and central nervous system. The patient died 
20 months after the diagnosis of oral metastatic melano-
ma even though she was under palliative care and care-
ful medical follow-up. 
Discussion
The oral region is an uncommon site for metastatic tumor 
cell colonization. Still, there are many reported cases of 
oral metastases being the first indication of undiscove-
red malignancies. In the oral soft tissues, the attached 
gingiva seems to be the most common site for metastatic 
colonization and it usually resembles a hyperplastic or 
reactive lesion, such as pyogenic granuloma, periphe-
ral giant cell granuloma, or fibrous epulis. In locations 
other than the gingiva, it may present as a submucosal 
mass(8), as seen in case 2.
Both cases of metastatic melanoma described in this re-
port had primary tumors of the skin and one of them was 
a clinical finding during a dental assessment. A gap of 
several years between the time of treatment of primary 
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Fig. 2: A. Submucosal nodular lesion in the tongue. B. Histopathological findings of an 
oral lesion showing epithelioid malignant cells. C. Immunoreactivity for HMB-45. D. and 
Melan-A.
melanoma and the appearance of metastasis as seen in 
these reports is a common finding(9), and metastases to 
the head and neck mucosa are frequent manifestations 
of widespread disease(10). In the present paper, patient 
1 presented disease progression including subcutaneous 
nodules on the dorsum, osteolytic lesions in the iliac 
and femur bones, ribs, vertebrae, sternum, scapula and 
a pulmonary mass, while patient 2 presented metastatic 
disease in the lung, subclavicular and retroperitoneal re-
gion and central nervous system. The literature review 
provided eight complete detailed cases of melanoma 
metastatic to the tongue available in the English langua-
ge (1, 5, 6, 7) (Table 1). Mean patient age in these ca-
ses was 50 years and cutaneous melanoma was the most 
frequent primary site accounting for all primary tumors. 
One case (12.5%) of oral metastasis was treated exclusi-
vely by surgery, one (12.5%) was treated by surgery and 
local adjuvant radiotherapy and one (12.5%) was treated 
by palliative chemotherapy and local radiotherapy. Both 
cases described in this report were treated first by surgi-
cal resection and after the diagnosis of distant metasta-
ses by chemotherapy with palliative purposes. The mean 
time for developing a tongue metastasis in the literature 
review was 4.9 years (ranging from 1.25 to 10 years), 
while in our report, one patient presented a tongue me-
tastasis six years after the initial diagnosis and the other 
after four years.
A consensus is lacking on treatment for metastatic me-
lanoma. Systemic therapy is based on many chemothe-
rapeutic protocols; however, these have been used with 
varying success and little improvement in median survi-
val. Immunomodulatory agents are also used but have 
low response rates, many side effects and are not recom-
mended for all patients (11). 
 Hope relies in targeted agents such as ipilimumab and 
vemurafenib, which are revolutionizing the treatment of 
metastatic melanoma (12,13). Both patients in our report 
had many metastatic lesions and were treated by pallia-
tive protocols due to the inability to control disease pro-
gression. The prognosis in these cases is often very bad, 
and both patients died after 4 and a half and 20 months 
respectively. 
Melanomas can histologically mimic a wide variety of 
neoplasms, including poorly differentiated carcinomas, 
high-grade lymphomas and even round cell sarcomas 
(6). Besides the epithelioid phenotype, the intracyto-
plasmic melanin deposits and eosinophilic macronu-
cleolus are the most reliable histomorphological clues to 
melanoma diagnosis. However, some cases do not show 
the usual features and may represent a challenge for the 
precise microscopic detection. In the metastatic disease, 
it is not uncommon to see amelanotic lesions, probably 
due to the selection of poorly differentiated tumor cell 
clones.  In addition, not only the pigment can be lesse-
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ned or even absent but also the nuclear features and/or 
the cytoplasmic conformation. Spindle cell melanomas 
may be difficult to distinguish from round cell sarcomas, 
sarcomatoid carcinomas, or even an inflammatory sca-
rring process (14). Small cell tumor phenotype includes 
other differential diagnoses, such as lymphoproliferati-
ve diseases and round cell sarcomas. In such settings, 
immunohistochemistry represent a highly valuable 
diagnostic tool. The most useful melanocytic-related 
markers are S100 protein, HMB-45 and Melan-A (also 
known as MART-1). All of them are expected to be posi-
tive in melanocytic neoplasms, even though their sensi-
tivity and specificity may vary, with S100 protein being 
regarded as the most sensitive and HMB-45 and Me-
lan-A as the most specific. This consistent melanocytic 
profile should be associated to negative immunostaining 
for other malignancies coming from the histomorpholo-
gical analysis, such as lymphoid markers (CD45, CD20, 
CD3), epithelial markers (cytokeratins, epithelial mem-
brane antigen, BER-EP4), mesenquimal markers (WT-1, 
CD99, desmin, muscle actins) and neuroendocrine mar-
kers (sinaptophysine, cromogranin), among others.
Conclusion
Tongue metastases of melanoma are rare and are asso-
ciated with widespread disease and consequently poor 
prognosis and low survival rates, as seen in the cases 
described here. Health professionals should always give 
importance to the patient’s medical history and perform 
a systematic oral examination to provide an early diag-
nosis to improve treatment and survival. Finally, metas-
tatic tumors should always be included in the differential 
diagnosis of oral lesions in patients with a previous me-
dical history of cancer.
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